Heart failure & cardiomyopathies

Left Bundle Branch Area Pacing Versus Biventricular Pacing as Initial Strategy for Cardiac Resynchronization

JACC Clin ElectrophysiolPublished Prospective cohort study

Main findingResult — go to the resultHazard ratio 0.621 95% CI 0.415–0.93

Authors' conclusion

LBBAP as an initial CRT strategy resulted in a lower risk of HF-related hospitalizations compared to BiVp. A reduction in procedural and fluoroscopy times, shorter paced QRS duration, and improvements in left ventricular ejection fraction compared with BiVp were observed.

Study context

Population
First-time cardiac resynchronization therapy (CRT) implant recipients
Participants
371 recipients
Exposure
Left bundle branch area pacing (LBBAP) vs biventricular pacing (BiVp) as initial CRT implant strategy
Outcome
Composite of:
  • Heart failure (HF)-related hospitalisation
  • All-cause mortality
Follow-up
Median 340 days (IQR 206-477 days)
Methodological detailsmulticentre, observational, nonrandomised
  • Multicentre
  • Observational
  • Nonrandomised

Main finding

As reported in the abstract

Hazard ratio

0.621

95% CI 0.415–0.93

P = 0.021

By group

LBBAPvs BiVp
HR 0.621 (95% CI 0.415–0.93); P = 0.021

Observational data: associations, not effects.

Secondary outcomes

OutcomeLBBAPBiVpHR (95% CI)P value
HF-related hospitalisation (primary component)22.6%39.5%0.607 (0.397–0.927)P = 0.021

All-cause mortality (primary component) · not significant

P = 0.19

Procedural time

P < 0.001

Fluoroscopy time

P < 0.001

QRS duration

P < 0.001

OutcomeLBBAPBiVpP value
Postprocedural LVEF34.1% (SD 12.5%)31.4% (SD 10.8%)P = 0.041

Safety

Long-term complications · no significant difference

P = 0.146

Original publication

Left Bundle Branch Area Pacing Versus Biventricular Pacing as Initial Strategy for Cardiac Resynchronization. JACC Clin Electrophysiol. Published 21 May 2023. doi:10.1016/j.jacep.2023.04.015

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.